Bryan W Day

7PUBLICATIONS
93CO-AUTHORS
Haematological tumoursLiquid biopsiesMolecular targetsAfrican languagesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 10, 2026
A Phase I and Biodistribution Study of Ifabotuzumab, a Humanized Agonistic EphA3-Targeted Antibody, in Patients with Recurrent Glioblastoma.

|Jan 30, 2026
Monitoring glioblastoma extracellular vesicle evolution using a nanodiagnostic platform to detect glioma stem cells driving recurrent disease.

Zhen Zhang, Richard J Lobb, Paul Tooney

|May 17, 2023
ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma.

Evangeline R Jackson, Ryan J Duchatel, Dilana E Staudt

|May 05, 2023
ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma.

Evangeline R Jackson, Ryan J Duchatel, Dilana E Staudt

|Dec 22, 2022
Determining the Research Priorities for Adult Primary Brain Tumours in Australia and New Zealand: A Delphi Study with Consumers, Health Professionals, and Researchers.

Georgia K B Halkett, Lauren J Breen, Melissa Berg

|Aug 30, 2019
The dystroglycan receptor maintains glioma stem cells in the vascular niche.

Bryan W Day, Justin D Lathia, Zara C Bruce

Pageof 2

Frequent Collaborators

2 joint publications

Evangeline R Jackson

2 joint publications

Ryan J Duchatel

2 joint publications

Dilana E Staudt

2 joint publications

Mika L Persson